# Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys

> **NCT00133354** · PHASE2,PHASE3 · COMPLETED · sponsor: **Nemours Children's Clinic** · enrollment: 53 (actual)

## Conditions studied

- Hypopituitarism

## Interventions

- **DRUG:** Arimidex (Anastrozole)
- **DRUG:** Placebo
- **DRUG:** Growth Hormone

## Key facts

- **NCT ID:** NCT00133354
- **Lead sponsor:** Nemours Children's Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2006-08
- **Final completion:** 2010-08
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2011-10-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00133354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00133354, "Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00133354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*